Cite
APA Citation
Tardieu, M., Néron, A., Duvert‐Lehembre, S., Amine Larabi, I., Barkaoui, M., Emile, J., Seigneurin, A., Boralevi, F., & Donadieu, J. (2021). cutaneous adverse events in children treated with vemurafenib for refractory BRAFV600E mutated Langerhans cell histiocytosis. Pediatric blood & cancer, 68(9), n/a. http://access.bl.uk/ark:/81055/vdc_100135172538.0x00001f